NCT00004013View on ClinicalTrials.gov

Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

paclitaxel

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00004013 - Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter